Abivax S.A.
ABVX | NASDAQ
$105.04
-$1.95 (-1.82%)
At close: Sep 18, 2026, 4:00 PM ET
$106.16
+$1.12 (+1.07%)
Pre-market:
Sep 21, 2026, 8:54 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 63K |
Cost of Revenue | n/a | n/a | n/a | 50.76M | 45.52M | 33.78M |
Gross Profit | n/a | n/a | n/a | -50.76M | -45.52M | -33.78M |
Operating Income | -246.06M | -172.98M | -127.38M | -64.84M | -41.4M | -38.01M |
Interest Income | 5.75M | 8.96M | 2.77M | n/a | n/a | n/a |
Pretax Income | -330.25M | -176.24M | -147.74M | -60.74M | -42.45M | -40.13M |
Net Income | -336.1M | -176.24M | -147.74M | -60.74M | -42.45M | -37.55M |
Selling & General & Admin | 72.87M | 38.9M | 28.82M | 7.49M | 5.58M | 5.6M |
Research & Development | 177.76M | 146.53M | 103.18M | 48.3M | 47.78M | n/a |
Other Expenses | -4.57M | -12.45M | -4.62M | -41.72M | -57.48M | -1.37M |
Operating Expenses | 246.06M | 172.98M | 127.38M | 14.07M | -4.12M | 4.23M |
Interest Expense | 28.48M | 12.43M | 13.83M | 6.94M | 3.56M | 2.06M |
Selling & Marketing Expenses | 224K | 932K | 709K | n/a | n/a | n/a |
Cost & Expenses | 246.06M | 172.98M | 127.38M | 64.84M | 41.4M | 38.01M |
Income Tax Expense | 5.85M | n/a | n/a | n/a | n/a | -2.58M |
Shares Outstanding (Basic) | 69.53M | 63.05M | 43.07M | 19.09M | 15.46M | 14.31M |
Shares Outstanding (Diluted) | 69.53M | 63.05M | 43.07M | 19.09M | 15.46M | 14.31M |
EPS (Basic) | -4.65 | -2.80 | -3.43 | -3.18 | -2.75 | -2.62 |
EPS (Diluted) | -4.65 | -2.80 | -3.43 | -3.18 | -2.75 | -2.62 |
EBITDA | -300.7M | -162.71M | -133.21M | -53.32M | -38.59M | -38M |
EBIT | -301.77M | -163.81M | -133.91M | -53.8M | -38.89M | -38.07M |
Depreciation & Amortization | 1.07M | 1.1M | 707K | 485K | 302K | 66K |
Add to Watchlist
Select watchlists to add or remove ABVX